Dermatologists can now Prescribe Tofacitinib: CDSCO Committee MD Bureau19 Jan 2021 5:38 PM ISTNew Delhi: In the latest development Pfizer has earned approval from the Central Drugs Standard Control Organization (CDSCO) committee regarding the...
CDSCO Panel Gives Conditional nod to Azelnidipine and Olmesartan FDC MD Bureau18 Jan 2021 6:51 PM ISTNew Delhi: Following the submission of bioequivalence (BE) study report by Akum Drugs, the Central Drug Standard Control...
AstraZeneca gets CDSCO nod for Dapagliflozin in CKD MD Bureau17 Jan 2021 3:30 PM ISTNew Delhi: The Subject Expert Committee (SEC), operative under the Central Drugs Standard Control Organization (CDSCO), has given its nod to...
Emcure Secures CDSCO Committee nod for manufacturing, marketing of Metoprolol Telmisartan FDC MD Bureau16 Jan 2021 5:01 PM ISTNew Delhi: After reviewing the Bioequivalence (BE) study report of the fixed-dose combination (FDC) of Metoprolol Telmisartan, the Central Drugs...
Cadila Healthcare gets CDSCO panel go-ahead for Phase 3 trial of Novel Corona Virus 2019-nCoV Vaccine MD Bureau7 Jan 2021 5:28 PM ISTNew Delhi: Pharmaceutical major, Cadila Healthcare has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Wockhardt secures CDSCO panel conditional nod to conduct Phase IV Trial of Levonadifloxacin MD Bureau6 Jan 2021 6:18 PM ISTNew Delhi: Pharmaceutical and biotechnology major Wockhardt Ltd. has recently secured permission from the Subject Expert Committee (SEC) of the...
CDSCO panel directs Themis Medicare to conduct blinded trial of Inosine Pranobex in Moderate Covid-19 patient MD Bureau3 Jan 2021 11:00 AM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organisation (CDSCO) recently recommended Themis...
Eli Lilly gets CDSCO Committee nod for marketing authorization for Insulin Lispro MD Bureau1 Jan 2021 6:17 PM ISTNew Delhi: In a major rejoice to Eli Lilly and Company (India) Pvt. Ltd., the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
CDSCO panel asks Hetero to resubmit Bioequivalence protocol for Trelagliptin Succinate tablet MD Bureau30 Dec 2020 7:12 PM ISTNew Delhi: Noting that the protocol was not scientifically designed and the safety of the study subjects was not taken care of, the Subject Expert...
Semaglutide to be sold only on prescription of Endocrinologist, PG Medicine in India: CDSCO Committee Farhat Nasim22 Dec 2020 4:58 PM ISTNew Delhi: In a major development, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organisation (CDSCO) has...
